Early-Onset Pulmonary Events with Combined Brigatinib and Afatinib Treatment of L858/ cisT790M/cisC797S NSCLC: A Case Report

Patient: Female, 54-year-old Final Diagnosis: Interstitial lung disease Symptoms: Dyspnea Medication:— Clinical Procedure: — Specialty: Critical Care Medicine OBJECTIVE: Unusual or unexpected effect of treatment BACKGROUND: Brigatinib is used for anaplastic lymphoma kinase (ALK)-positive lung cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Bing-Jie, Lim, Chor-Kuan, Chang, Hou-Tai, Zhang, Jia-Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513817/
https://www.ncbi.nlm.nih.gov/pubmed/36146910
http://dx.doi.org/10.12659/AJCR.937209

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513817/
https://www.ncbi.nlm.nih.gov/pubmed/36146910
http://dx.doi.org/10.12659/AJCR.937209

Ejemplares similares